Oneness Biotech Co., Ltd.

This study tests a new medicine called FB704A in adults with severe asthma. The goal is to see if it is safe and can help control asthma symptoms. About 20 people will receive either the drug or a placebo over 8 weeks, with follow-up for 12 more weeks.

This study reviewed medical records of 160 people with diabetic foot ulcers who had previously been in a treatment trial. The goal was to understand the total medical costs and rates of amputation linked to these wounds. No new treatments were given; the study simply gathered exi…